Malignant transformation of gastric hyperplastic polyps: Alteration of phenotypes, proliferative activity, and p53 expression

被引:44
|
作者
Yao, T
Kajiwara, M
Kuroiwa, S
Iwashita, A
Oya, M
Kabashima, A
Tsuneyoshi, M
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Fukuoka 8128582, Japan
[2] Fukuoka Univ, Sch Med, Dept Pathol, Fukuoka 81401, Japan
关键词
hyperplastic polyp; adenocarcinoma; phenotypic expression; Ki-67; p53;
D O I
10.1053/hupa.2002.126874
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aim of this study was to clarify the mechanism of malignant transformation of gastric hyperplastic polyps, focusing on phenotypic expression, cell proliferation, and p53 overexpression. Twenty-two lesions of gastric hyperplastic polyps with neoplastic foci were selected for this study. The phenotypes were divided into 3 types (G, gastric; incomp I, incomplete intestinal; and comp I, complete intestinal), according to immunohistochemical stains (human gastric mucin [HGM], MUC2, and CD10). The cell proliferative activity by Ki-67 and overexpression of p53 protein were also examined. Eleven of these lesions contained carcinoma components (CA, category 5 by the Vienna classification), 6 of which were accompanied by low-grade dysplasia (LGD, category 3) and 4 of which were accompanied by high-grade dysplasia (HGD, category 4). Another 2 were composed only of HGD, and the remaining 9 were composed of both LGD and HGD components. As a result, 15 LGD, 15 HGD, and 11 CA components were recognized. The 15 LGD components were classified as 1 G type and 14 incomp I type. All hyperplastic components expressed HGM, 5 (22.7%) of which were accompanied by focal intestinal metaplasia. demonstrated by MUC2 expression, whereas intestinalization frequently occurred in neoplastic components (93% of LGD, 53% of HGD, and 64% of CA components). The labeling index was 22.2% in hyperplastic, 42.2% in LGD, 55.7% in HGD, and 53.9% in CA components. p53 protein overexpression was recognized in none of hyperplastic, in 40% of the LGD, in 60% of the HGD, and in 45% of the CA components. These results suggest the importance of the dysplasia-carcinoma sequence in malignant transformation of hyperplastic polyps. Interestingly, intestinalization frequently occurs during neoplastic transformation, although it is not common in the surrounding hyperplastic components. Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:1016 / 1022
页数:7
相关论文
共 50 条
  • [1] The relationship between mucin phenotype and clinicopathological factors, proliferative activity and p53 expression in gastric hyperplastic polyps
    Li, Juan
    Wu, Li-Hua
    Shi, Yan
    Li, Hua-Min
    Song, Mei-Yue
    Jiao, Yu-Fei
    HISTOLOGY AND HISTOPATHOLOGY, 2014, 29 (03) : 343 - 351
  • [2] CORRELATION OF P53 EXPRESSION AND PROLIFERATIVE ACTIVITY IN GASTRIC-CANCER
    YONEMURA, Y
    FUSHIDA, S
    TSUGAWA, K
    NINOMIYA, I
    FONSECA, L
    YAMAGUCHI, A
    MIYAZAKI, I
    URANO, T
    SHIKU, H
    ANALYTICAL CELLULAR PATHOLOGY, 1993, 5 (05): : 277 - 288
  • [3] Expression of p53 protein in gastric cancer: An immunohistochemical study with correlation to proliferative activity
    Ioachim, E
    Goussia, A
    Stefanou, D
    Agnantis, NJ
    ANTICANCER RESEARCH, 1997, 17 (1A) : 513 - 517
  • [4] Differential p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: Possible sequences of p53 alteration in stomach carcinogenesis
    Kushima, R
    Muller, W
    Stolte, M
    Borchard, F
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1996, 428 (4-5): : 223 - 227
  • [5] Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium
    Cinel, L
    Polat, A
    Aydin, Ö
    Düsmez, D
    Egilmez, R
    PATHOLOGY INTERNATIONAL, 2002, 52 (5-6) : 384 - 389
  • [6] Increased p53 Expression in the Malignant Transformation of Barrett's Esophagus is Accompanied by an Upward Shift of the Proliferative Compartment
    Hritz, Istvan
    Gyorffy, Hajnalka
    Molnar, Bela
    Lakatos, Gabor
    Sipos, Ferenc
    Pregun, Istvan
    Juhasz, Mark
    Pronai, Laszlo
    Schaff, Zsuzsa
    Tulassay, Zsolt
    Herszenyi, Laszlo
    PATHOLOGY & ONCOLOGY RESEARCH, 2009, 15 (02) : 183 - 192
  • [7] Expression of p53 in endometrial polyps with special reference to the p53 signature
    Sho, Tomoko
    Hachisuga, Toru
    Kawagoe, Toshinori
    Urabe, Rie
    Kurita, Tomoko
    Kagami, Seiji
    Shimajiri, Shohei
    Fujino, Yoshihisa
    HISTOLOGY AND HISTOPATHOLOGY, 2016, 31 (07) : 751 - 758
  • [8] p53 expression, proliferative activity and prognosis in cancer
    Pich, A
    CANCER JOURNAL - FRANCE, 1998, 11 (05): : 223 - 228
  • [9] Analysis of p53 expression in precancerous and malignant gastric mucosa
    Romiti, A
    Moretti, A
    Vecchione, A
    Muraro, R
    Feudi, ML
    Rinaldi, V
    Mancini, R
    Valli, C
    Mozzicafreddo, A
    Frati, L
    Tomao, S
    ONCOLOGY REPORTS, 1998, 5 (01) : 109 - 113
  • [10] p53, But not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps
    Murakami, K
    Mitomi, H
    Yamashita, K
    Tanabe, S
    Saigenji, K
    Okayasu, I
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 115 (02) : 224 - 234